drugset / Trial / NCT02170597
Bioavailability of BIBR 953 ZW Under Influence of Food in Healthy Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
Study to investigate the relative bioavailability of BIBR 953 ZW after administration of a 150 mg BIBR 1048 HPMC (hydroxypropylmethylcellulose) capsule versus BIBR 953 ZW after administration of a 150 mg BIBR 1048 gelatine capsule, and to investigate the relative bioavailability of BIBR 953 ZW given as BIBR 1048 MS HPMC capsule with food versus without food.
Timeline
- Start
- 2003-08
- Primary completion
- 2003-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dabigatran etexilate | Unknown | 150 mg | Oral |
Indications
No indication recorded.